Darunavir/cobicistat

Darunavir/cobicistat, sold under the brand names Prezcobix (US) and Rezolsta (EU), is a fixed-dose combination antiretroviral medication used to treat and prevent HIV/AIDS. It contains darunavir and cobicistat. Darunavir is an HIV protease inhibitor and cobicistat increases the effectiveness of darunavir by blocking its metabolism by the enzyme CYP3A.

Darunavir/cobicistat was approved for use in the European Union in November 2014, and for use in the United States in January 2015.

References

External links

• "Cobicistat". MedlinePlus.
• "Darunavir". MedlinePlus.